Exponent, Inc. (EXPO) Stock Forecast
EXPO analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.25 / 5 from 4 analysts
- Price target
- $84.00 average of analyst targets
- Upside to target
- +16.9% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $0.60
- 52-week range
- $53.67 – $79.79
EXPO analyst ratings
4 analystsNumber of analysts at each rating.
EXPO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
EXPO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.62 | $0.59 | $0.69 | $0.55 | +12.9% | 4 |
| Current fiscal year (2026) | $2.41 | $2.30 | $2.71 | $2.07 | +16.4% | 4 |
| Next fiscal year (2027) | $2.72 | $2.58 | $3.08 | $2.41 | +12.9% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
EXPO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $153.4M | $149.3M | $161.0M | +11.9% | 3 |
| Current fiscal year (2026) | $612.1M | $587.7M | $659.0M | +14.0% | 3 |
| Next fiscal year (2027) | $663.9M | $633.1M | $725.0M | +8.5% | 3 |
EXPO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
EXPO revenue: reported and forecast
EXPO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.64 | $0.65 | $0.65 | $0.65 | $0.62 | −2.6% | 0 up · 1 down |
| Current fiscal year (2026) | $2.47 | $2.51 | $2.51 | $2.51 | $2.41 | −2.4% | 0 up · 1 down |
| Next fiscal year (2027) | $2.76 | $2.84 | $2.84 | $2.84 | $2.72 | −1.4% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
EXPO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; EXPO beat in 9 of 12.
What analysts expect from EXPO
4 analysts cover Exponent; their consensus rating is buy (4.25 on a 1–5 scale, where 5 is a strong buy). The average price target is $84.00, 16.9% above the latest close of $71.85. Analysts expect earnings of $2.41 per share for 2026, +16.4% from a year earlier. For 2027 the average estimate is $2.72 per share on revenue of $663.9 million. Exponent beat the EPS estimate in 9 of the last 12 quarters.
Related: EXPO income statement, EXPO key metrics, EXPO chart. See the EXPO stock overview for the latest quote and news.
EXPO forecast FAQ
What is Exponent's price target?
The average analyst price target for Exponent is $84.00, 16.9% above the latest close of $71.85.
Is Exponent a buy, hold or sell?
Of 4 analysts covering Exponent, 2 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Exponent's EPS forecast?
Analysts forecast $2.41 per share for 2026 (range $2.30 to $2.71); for 2027 the estimate is $2.72.
What is Exponent's revenue forecast?
The average revenue estimate for 2026 is $612.1 million, growth of 14.0%; for 2027 it is $663.9 million.
When does Exponent report earnings?
Exponent is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes; the EPS estimate is $0.60.
Does Exponent usually beat earnings estimates?
Exponent reported EPS at or above the analyst estimate in 9 of the last 12 quarters.